-
- Anke R. Vollertsen
- Applied Stem Cell Technologies, University of Twente 1 , Enschede, the Netherlands
-
- Aisen Vivas
- Applied Stem Cell Technologies, University of Twente 1 , Enschede, the Netherlands
-
- Berend van Meer
- Organ-on-Chip Center Twente, University of Twente 3 , Enschede, the Netherlands
-
- Albert van den Berg
- BIOS Lab on a Chip Group, MESA+ Institute for Nanotechnology, Max Planck Institute for Complex Fluid Dynamics, University of Twente 2 , Enschede, the Netherlands
-
- Mathieu Odijk
- BIOS Lab on a Chip Group, MESA+ Institute for Nanotechnology, Max Planck Institute for Complex Fluid Dynamics, University of Twente 2 , Enschede, the Netherlands
-
- Andries D. van der Meer
- Applied Stem Cell Technologies, University of Twente 1 , Enschede, the Netherlands
書誌事項
- 公開日
- 2021-09-01
- 権利情報
-
- https://creativecommons.org/licenses/by/4.0/
- https://creativecommons.org/licenses/by/4.0/
- DOI
-
- 10.1063/5.0063428
- 公開者
- AIP Publishing
説明
<jats:p>Organ-on-chip (OoC) and multi-organs-on-chip (MOoC) systems have the potential to play an important role in drug discovery, disease modeling, and personalized medicine. However, most devices developed in academic labs remain at a proof-of-concept level and do not yet offer the ease-of-use, manufacturability, and throughput that are needed for widespread application. Commercially available OoC are easier to use but often lack the level of complexity of the latest devices in academia. Furthermore, researchers who want to combine different chips into MOoC systems are limited to one supplier, since commercial systems are not compatible with each other. Given these limitations, the implementation of standards in the design and operation of OoCs would strongly facilitate their acceptance by users. Importantly, the implementation of such standards must be carried out by many participants from both industry and academia to ensure a widespread acceptance and adoption. This means that standards must also leave room for proprietary technology development next to promoting interchangeability. An open platform with standardized interfacing and user-friendly operation can fulfill these requirements. In this Perspective article, the concept of an open platform for OoCs is defined from a technical perspective. Moreover, we discuss the importance of involving different stakeholders in the development, manufacturing, and application of such an open platform.</jats:p>
収録刊行物
-
- Biomicrofluidics
-
Biomicrofluidics 15 (5), 051301-, 2021-09-01
AIP Publishing